A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment

NCT01836185 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Insufficiency

Interventions

DRUG: Evacetrapib

Sponsor

Eli Lilly and Company